Year: 2022

Biocytogen27s_LOGO-1

US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab

BEIJING & SAN DIEGO--(BUSINESS WIRE)--#Biocytogen--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that...

Acumen-Research-and-Consulting-23

Inspection Machines Market Size Will Achieve USD 1,179 Million by 2030 growing at 5.5% CAGR – Exclusive Report by Acumen Research and Consulting

Acumen Research and Consulting recently published report titled “Inspection Machines Market Share, Analysis Report and Region Forecast, 2022 - 2030”...